Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03437993
Other study ID # Recollect_ADHD
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 14, 2019
Est. completion date February 28, 2025

Study information

Verified date October 2023
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Adults who have attention deficit hyperactivity disorder (ADHD) suffer from significant occupational, academic and social problems, many of which are believed to be a result of problems with executive functioning. Executive functioning refers to a group of neuro-psychological functions which include sustained attention, working memory, verbal fluency, as well as motor and mental processing speed. Individuals with ADHD have been shown to have deficits in executive functioning independent of IQ, co-occurring psychiatric disorders, gender, and ADHD subtype. "Recollect" is an application (App) based working memory training video game where participants conduct 3-different adaptive working memory tasks. In each of these tasks participants are presented with a set of stimuli to be remembered while playing a simple platform game where they help navigate an astronaut across the screen and dodge obstacles. Recollect has been designed for all age groups to an interesting, fun and effective brain-training activity. The memory tasks included in the game have been independently shown to improve working memory in a manner that transfers to untrained tasks. The purpose of this study is to evaluate the effects of playing Recollect versus Tetris for 20 minutes per day, 5 days per week over a 4 week period, on executive functioning deficits in individuals who have Adult ADHD.


Description:

The primary objective is to evaluate the effects of playing Recollect versus Tetris for 20 minutes per day, 5 days per week over a 4 week period, on executive functioning deficits in individuals who have Adult Attention Deficit Hyperactivity Disorder (ADHD).Consenting participants will be screened using the Mini International Neuropsychiatric Interview for DSM-5 (MINI) to confirm ADHD diagnosis. Participants will be asked to download either Recollect or Tetris on their own mobile device. Following a training/orientation session, they will be asked to spend 20 minutes per day at least 5 days per week playing Recollect or Tetris over a 4 week period. At Week 4, study staff will check the time log on the Recollect/Tetris App to confirm how much time was spent playing the game. Participants will be asked to complete two ADHD symptom severity scales, as well as App-based neurocognitive testing at baseline (Week 0) and endpoint (Week 4).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 40
Est. completion date February 28, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Males and females aged 18 and older who own a mobile device such as a Smartphone or tablet. 2. Current diagnosis of Adult ADHD, at any stage of treatment. 3. Comorbid psychiatric conditions will be allowed. 4. Medication or psychotherapy must have been stable (no dose changes) for 4 weeks prior to study participation. 5. Must be able to read, write and understand English. Exclusion Criteria: 1. Participant does not own a Smartphone or tablet. 2. No dose changes during the 4 week study period. 3. No initiation of new psychological therapy or counselling during the 4 week study period.

Study Design


Related Conditions & MeSH terms

  • Adult ADHD
  • Attention Deficit Disorder with Hyperactivity

Intervention

Other:
Recollect, the game
"Recollect" is a working memory training game
Tetris
App-based video game where shapes are rotated and placed to fit a grid

Locations

Country Name City State
Canada MacAnxiety Research Centre Hamilton Ontario

Sponsors (1)

Lead Sponsor Collaborator
McMaster University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline on The Behavioral Rating Inventory of Executive Functioning - Adult Version (BRIEF-A) It is a validated, clinician-rated scale, measuring executive functioning. The scale includes 75 items that rates patient symptoms on a 3-point Likert scale (1 = behavior is never observed to 3 = behavior is often observed). Scores range from 75 to 225: Higher scores indicate greater impairment in executive functioning. Change from baseline to week 4
Secondary Change from baseline on the Barkley Adult ADHD Rating Scale (BAARS-IV) Self-report scale evaluating ADHD symptoms. Symptom count scores range from 1 to 27, with higher scores indicating more ADHD symptoms. Total scores range from 27 to 108, with higher scores indicating greater severity of symptoms. Change from baseline to week 4
Secondary Change from baseline on an App-based neuro-cognitive battery A number of neuro-cognitive executive functioning tests, which will be administered via a smartphone application Change from baseline to week 4
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03494478 - Emotional Dysregulation in Adult ADHD. N/A
Completed NCT01939353 - Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder Phase 2
Completed NCT01012375 - Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients. Phase 2
Active, not recruiting NCT06040996 - Evaluation of Improving Parenting Skills Adult ADHD (IPSA): A New Parent Training Program for Parents With ADHD N/A
Recruiting NCT05832489 - EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders Phase 3
Completed NCT00318981 - Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD Phase 4